# Severe LH Suppressed Patients After Administration of a GnRH Antagonist

> **NCT01936077** · PHASE4 · COMPLETED · sponsor: **Assuta Hospital Systems** · enrollment: 50 (actual)

## Conditions studied

- Infertility, Female Infertility, Male Infertility

## Interventions

- **DRUG:** Recombinant LH (Luveris)

## Key facts

- **NCT ID:** NCT01936077
- **Lead sponsor:** Assuta Hospital Systems
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01936077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01936077, "Severe LH Suppressed Patients After Administration of a GnRH Antagonist". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01936077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*